{"public_id":"cl_1f4ab5a6085bb20c5a878b89a9463e17","status":"active","superseded_by_public_id":null,"corpus_id":210978506,"text":"Adding twice-lifetime screening enables 100% of LMICs to reach elimination for all three thresholds (≤4, ≤10, ≥85% reduction).","confidence":0.9,"paper":{"corpus_id":210978506,"title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","url":"https://sah.borca.ai/papers/210978506"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_4fcc5ac9a8c59cc1eb6fd5c72c644339","name":"low-income and lower-middle-income countries","description":"The 78 LMICs included in the modelling analysis.","types":["population"],"url":"https://sah.borca.ai/concepts/co_4fcc5ac9a8c59cc1eb6fd5c72c644339"},{"public_id":"co_7f0e87b022292eabc59fb7629e7c2eea","name":"twice-lifetime screening","description":"Cervical screening involving HPV testing once or twice per lifetime at ages 35 and 45, with uptake increasing from 45% (2023) to 90% (2045 onwards).","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_7f0e87b022292eabc59fb7629e7c2eea"},{"public_id":"co_8dfd530d6c48986e0b4e41c247d5c8eb","name":"cervical cancer elimination thresholds","description":"The three thresholds examined: average age-standardised incidence ≤4 per 100,000 women-years, ≤10 per 100,000 women-years, and ≥85% reduction in incidence.","types":["criterion"],"url":"https://sah.borca.ai/concepts/co_8dfd530d6c48986e0b4e41c247d5c8eb"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_1f4ab5a6085bb20c5a878b89a9463e17"}